Unprecedented oxidation of a phenylglycinol-derived 2-pyridone: Enantioselective synthesis of polyhydroxypiperidines

Organic Letters

Volumn 3, Issue 21, 2001, Pages 3257-3260

  Amat, Mercedes ^a   Llor, Núria ^a   Huguet, Marta ^a   Molins, Elies ^b   Espinosa, Enrique ^b   Bosch, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPYRIDINE; 2-HYDROXYPYRIDINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GLYCINE; GLYCOSIDASE; PHENYLGLYCINOL; PIPERIDINE DERIVATIVE; PYRIDONE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG ANTAGONISM; OXIDATION REDUCTION REACTION; STEREOISOMERISM; SYNTHESIS;

ENZYME INHIBITORS; GLYCINE; GLYCOSIDE HYDROLASES; OXIDATION-REDUCTION; PIPERIDINES; PYRIDONES; STEREOISOMERISM;

EID: 0035909621     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol016418z     Document Type: Article

References (43)

1. (a) Nash, R. J.; Watson, A. A.; Asano, N. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Elsevier: Oxford, 1996; Vol. 11, pp 345-376.
2. (b) Elbein, A. D.; Molyneux, R. J. In Comprehensive Natural Products; Barton, D., Nakanishi, K., Eds.; Elsevier: New York, 1999; Vol. 3, pp 129-160.
3. (a) Bols, M. Acc. Chem. Res. 1998, 31, 1.
4. (b) Iminosugars as Glycosidase Inhibitors. Nojirimicin and Beyond; Stütz, A. E., Ed.; Wiley-VCH: Weinheim, 1999.
5. (a) Horii, S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.; Matsui, K. J. Med. Chem. 1986, 29, 1038.
6. (b) Drugs Future 1986, 11, 1039; 1987, 12, 1157.
7. (b) Drugs Future 1986, 11, 1039; 1987, 12, 1157.
8. (c) Robinson, K. M.; Begovic, M. E.; Reinhart, B. L.; Heineke, E. W.; Ducep, J.-B.; Kastner, P. R.; Marshall, F. N.; Danzin, C. Diabetes 1991, 40, 825.
9. (a) Fleet, G. W. J.; Karpas, A.; Dwek, R. A.; Fellows, L. E.; Tyms, A. S.; Petursson, S.; Namgoong, S. K.; Ramsden, N. G.; Smith, P. W.; Son, J.-C.; Wilson, F.; Witty, D. R.; Jacob, G. S.; Rademacher, T. W. FEBS Lett. 1988, 237, 128.
10. (b) Taylor, D. L.; Sunkara, P.; Liu, P. S.; Kang, M. S.; Bowlin, T. L.; Tyms, A. S. AIDS 1991, 5, 693.
11. (a) Nishimura, Y. In Studies in Natural Products Chemistry; Attaur-Rahman, Ed.; Elsevier Science B. V.: Amsterdam, 1995; Vol. 16, pp 75-121.
12. (b) Gross, P. E.; Baker, M. A.; Carver, J. P.; Dennis, J. W. Clin. Cancer Res. 1995, 1, 935.
13. For reviews on the stereoselective synthesis of piperidines, see: (a) Bailey, P. D.; Millwood, P. A.; Smith, P. D. Chem. Commun. 1998, 633.
14. (b) Laschat, S.; Dickner, T. Synthesis 2000, 1781.
15. (a) Amat, M.; Llor, N.; Bosch, J. Tetrahedron Lett. 1994, 35, 2223.
16. (b) Amat, M.; Llor, N.; Hidalgo, J.; Hernández, A.; Bosch, J. Tetrahedron: Asymmetry 1996, 7, 977.
17. (c) Amat, M.; Pshenichnyi, G.; Bosch, J.; Molins, E.; Miravitlles, C. Tetrahedron: Asymmetry 1996, 7, 3091.
18. (d) Amat, M.; Llor, N.; Bosch, J.; Solans, X. Tetrahedron 1997, 53, 719.
19. (e) Amat, M.; Hidalgo, J.; Llor, N.; Bosch, J. Tetrahedron: Asymmetry 1998, 9, 2419.
20. (f) Amat, M.; Bosch, J.; Hidalgo, J.; Cantó, M.; Pérez, M.; Llor, N.; Molins, E.; Miravitlles, C.; Orozco, M.; Luque, J. J. Org. Chem. 2000, 65, 3074.
21. (g) Amat, M.; Pérez, M.; Llor, N.; Bosch, J.; Lago, E.; Molins, E. Org. Lett. 2001, 3, 611.
22. For reviews, see: (h) Meyers, A. I.; Brengel, G. P. Chem. Commun. 1997, 1.
23. (i) Groaning, M. D.; Meyers, A. I. Tetrahedron 2000, 56, 9843.
24. (j) For the use of related chiral bicyclic phenylglycinol-derived 2-cyanopiperidines, see: Husson, H.-P.; Royer, J. Chem. Soc. Rev. 1999, 28, 383.
25. Gnecco, D.; Marazano, C.; Enríquez, R. G.; Terán, J. L.; Sánchez S., M. R.; Galindo, A. Tetrahedron: Asymmetry 1998, 9, 2027.
26. 13C NMR), analytical, and/or HRMS data were obtained for all new compounds.
27. 4 and NMO, DMD or UHP led only to the recovery of the starting material. Similarly, the O-silyl protected (TBDMS) lactam derived from 1 was recovered unchanged after exposure to m-CPBA.
28. -3.
29. It has been demonstrated that related cis-3,8a bicyclic lactams equilibrate to the trans isomers; see ref 6f.
30. (a) Schwesinger, R.; Willaredt, J.; Bauer, T. In Stereoselective Synthesis (Houben-Weyl); Helmchen, G., Hoffmann, R. W., Mulzer, J., Schaumann, E., Eds.; Thieme: Stuttgart, 1996; Vol. 8, pp 4599-4697.
31. (b) Adam, W.; Schambony, S. B. Org. Lett. 2001, 3, 79 and references therein.
32. (a) For the Elbs peroxydisulfate oxidation of 2-pyridone to 5-hydroxy-2-pyridone, see: Behrman, E. J.; Pitt, B. M. J. Am. Chem. Soc. 1958, 80, 3717.
33. (b) For the dioxygenase-catalyzed cis-dihydroxylation of N-methyl-2-pyridone, see: Modyanova, L.; Azerard, R. Tetrahedron Lett. 2000, 41, 3865.
34. Rodríguez, R.; Estiarte, M. A.; Diez, A.; Rubiralta, M.; Colell, A.; García-Ruiz, C.; Fernández-Checa, J. C. Tetrahedron 1996, 52, 7727.
35. A similar stereoselectivity was observed in the NIS-promoted iodination of a phenylglycinol-derived 1,4-dihydropyridine: Lavilla, R.; Coll, O.; Nicolas, M.; Sufi, B. A.; Torrents, J.; Bosch, J. Eur. J. Org. Chem. 1999, 2997.
36. For previous enantioselective syntheses of 3-hydroxypiperidine, see: (a) Huh, N.; Thompson, C. M. Tetrahedron 1995, 51, 5935.
37. (b) Monterde, M. I.; Nazabadioko, S.; Rebolledo, F.; Brieva, R.; Gotor, V. Tetrahedron: Asymmetry 1999, 10, 3449 and references therein.
38. Meyers, A. I.; Andres, C. J.; Resek, J. E.; Woodall, C. C.; McLaughlin, M. A.; Lee, P. H.; Price, D. A. Tetrahedron 1999, 55, 8931.
39. For previous syntheses, see: (a) Bernotas, R. C.; Papandreou, G.; Urbach, J.; Ganem, B. Tetrahedron Lett. 1990, 31, 3393.
40. (b) Legler, G.; Stütz, A. E.; Immich, H. Carbohydr. Res. 1995, 272, 17.
41. (c) Godskesen, M.; Lundt, I.; Madsen, R.; Winchester, B. Bioorg. Med. Chem. 1996, 4, 1857.
42. Ichikawa, Y.; Igarashi, Y.; Ichikawa, M.; Suhara, Y. J. Am. Chem. Soc. 1998, 120, 3007.
43. For a previous synthesis, see: Chen, L.; Dumas, P.; Wong, C.-H. J. Am. Chem. Soc. 1992, 114, 741.